• Info
  • Insider Ownership

Insider Trading & Ownership of Helen Louise Collins

Location
South San Francisco, CA
Summary
The estimated net worth of Helen Louise Collins is at least $654,367 dollars as of 19 Feb 2026. Helen Louise Collins is the CHIEF MEDICAL OFFICER of Enliven Therapeutics, Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $654.4K.
Signature
/s/ Ben Hohl, by power of attorney
All Insider Reports
All Insider Reports

Notify me when Helen Louise Collins files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Helen Louise Collins

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ELVN Enliven Therapeutics, Inc. Chief Medical Officer $654,367 -$1,177,862 -64% 17 Feb 2026
IOBT IO Biotech, Inc. Director 05 Jun 2025
KURA Kura Oncology, Inc. Director 05 Jun 2025

Insider Transactions Reported by Helen Louise Collins:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.